N. BOZKOÇ VASİ Et Al. , "Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy," 25th European Congress of Endocrinology , İstanbul, Turkey, pp.729-730, 2023
BOZKOÇ VASİ, N. Et Al. 2023. Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy. 25th European Congress of Endocrinology , (İstanbul, Turkey), 729-730.
BOZKOÇ VASİ, N., YORULMAZ, G., GARBİOGLU, D. B., YILDIZ, B., & DİNCER, M., (2023). Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy . 25th European Congress of Endocrinology (pp.729-730). İstanbul, Turkey
BOZKOÇ VASİ, NESLİHAN Et Al. "Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy," 25th European Congress of Endocrinology, İstanbul, Turkey, 2023
BOZKOÇ VASİ, NESLİHAN B. Et Al. "Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy." 25th European Congress of Endocrinology , İstanbul, Turkey, pp.729-730, 2023
BOZKOÇ VASİ, N. Et Al. (2023) . "Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy." 25th European Congress of Endocrinology , İstanbul, Turkey, pp.729-730.
@conferencepaper{conferencepaper, author={NESLİHAN BOZKOÇ VASİ Et Al. }, title={Baseline Serum TSH Levels Predict the Thyroid Dsyfunction in Cancer Patients Treated with Tyrosine Kinase Inhibitors and Immumotherapy}, congress name={25th European Congress of Endocrinology}, city={İstanbul}, country={Turkey}, year={2023}, pages={729-730} }